3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Prostatic Neoplasms
17
Neoplasm Metastasis
2
Sarcoma, Ewing
1
Sarcoma
1
Osteosarcoma
1
Neoplasms
1
Lymphoma
1
Hematopoietic and Lymphatic System Neoplasm
1
Breast Neoplasms
1
Interventions
Temozolomide
6
Cyclophosphamide
5
cabozantinib
4
Vincristine
4
fludarabine
3
Radiotherapy
3
Irinotecan
3
liposomal doxorubicin
2
irinotecan sucrosofate
2
Zoledronic Acid
2
Topotecan
2
Specimen Handling
2
PM 01183
2
Ifosfamide
2
Etoposide
2
Eflornithine
2
Drug Therapy
2
Doxorubicin
2
trilaciclib
1
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
naxitamab
1
fluzoparib
1
fludarabine phosphate
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma, Ewing
×
Triptorelin Pamoate
×
Clear all
NCT05328258
2023-10-27
ProFertil
Karolinska University Hospital
Phase 3
Recruiting
500 enrolled